1. Home
  2. MNKD vs CNNE Comparison

MNKD vs CNNE Comparison

Compare MNKD & CNNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • CNNE
  • Stock Information
  • Founded
  • MNKD 1991
  • CNNE 2014
  • Country
  • MNKD United States
  • CNNE United States
  • Employees
  • MNKD N/A
  • CNNE N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • CNNE Restaurants
  • Sector
  • MNKD Health Care
  • CNNE Consumer Discretionary
  • Exchange
  • MNKD Nasdaq
  • CNNE Nasdaq
  • Market Cap
  • MNKD 1.4B
  • CNNE 1.2B
  • IPO Year
  • MNKD 2004
  • CNNE N/A
  • Fundamental
  • Price
  • MNKD $3.75
  • CNNE $21.08
  • Analyst Decision
  • MNKD Buy
  • CNNE Buy
  • Analyst Count
  • MNKD 4
  • CNNE 2
  • Target Price
  • MNKD $9.75
  • CNNE $22.00
  • AVG Volume (30 Days)
  • MNKD 3.2M
  • CNNE 879.1K
  • Earning Date
  • MNKD 08-06-2025
  • CNNE 08-07-2025
  • Dividend Yield
  • MNKD N/A
  • CNNE 2.30%
  • EPS Growth
  • MNKD 228.27
  • CNNE N/A
  • EPS
  • MNKD 0.10
  • CNNE N/A
  • Revenue
  • MNKD $297,595,000.00
  • CNNE $445,000,000.00
  • Revenue This Year
  • MNKD $13.72
  • CNNE N/A
  • Revenue Next Year
  • MNKD $15.21
  • CNNE $2.03
  • P/E Ratio
  • MNKD $35.96
  • CNNE N/A
  • Revenue Growth
  • MNKD 32.50
  • CNNE N/A
  • 52 Week Low
  • MNKD $3.63
  • CNNE $15.92
  • 52 Week High
  • MNKD $7.63
  • CNNE $22.36
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 35.30
  • CNNE 71.53
  • Support Level
  • MNKD $3.65
  • CNNE $19.77
  • Resistance Level
  • MNKD $4.00
  • CNNE $20.99
  • Average True Range (ATR)
  • MNKD 0.15
  • CNNE 0.43
  • MACD
  • MNKD 0.00
  • CNNE 0.04
  • Stochastic Oscillator
  • MNKD 12.16
  • CNNE 88.55

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About CNNE Cannae Holdings Inc.

Cannae Holdings Inc is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant Group, Dun & Bradstreet, Alight, BKFC, Corporate and Other. Majority of the company's revenue is generated from its Restaurant Group segment which represents the operations of O'Charley's and Ninety Nine Restaurants.

Share on Social Networks: